NAT-9 inhibitors are a class of chemical compounds designed to target and inhibit the activity of NAT-9 (N-acetyltransferase 9), an enzyme involved in the acetylation of proteins or small molecules. NAT enzymes, including NAT-9, catalyze the transfer of an acetyl group from acetyl-CoA to an amine group on specific substrates. This post-translational modification plays a crucial role in regulating protein function, stability, and localization, as well as in modulating other cellular processes such as metabolism and gene expression. NAT-9 is thought to have a specific set of substrates or functions that contribute to cellular homeostasis, and its inhibition allows researchers to explore how the acetylation of these targets influences cellular pathways and dynamics.
The mechanism by which NAT-9 inhibitors function generally involves blocking the enzyme's active site, preventing the acetylation reaction from occurring. These inhibitors may bind to the acetyl-CoA binding site or the substrate recognition domain, either competitively or allosterically. Structurally, NAT-9 inhibitors are often designed to resemble the enzyme's natural substrates or transition states of the acetylation reaction, allowing them to bind with high affinity and specificity. By studying NAT-9 inhibitors, researchers can gain insights into the specific role of NAT-9 in acetylation-related processes and how this modification affects various biological functions. The inhibition of NAT-9 provides valuable information on the regulation of protein modification and its broader impact on cellular signaling, protein interaction networks, and metabolic control, offering a deeper understanding of how acetylation modulates critical aspects of cell biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A could hyperacetylate histones near the NAT9 gene, leading to a tightly packed chromatin structure that may downregulate NAT9 transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting the methylation of DNA, 5-Azacytidine may decrease the expression of NAT9 by disrupting transcription factor binding at its promoter region. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG 108 may cause demethylation of the NAT9 promoter, reducing the recruitment of transcriptional machinery and thereby decreasing the expression of the NAT9 gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A could bind to the NAT9 gene's promoter, blocking the binding of essential transcription factors, leading to decreased levels of NAT9 mRNA. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine may inhibit lysosomal degradation, which could lead to a buildup of cellular waste and subsequent downregulation of various genes, including NAT9. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, which may inhibit RNA polymerase movement along the NAT9 gene, leading to a reduction in NAT9 mRNA synthesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin may lead to a reduced global protein synthesis rate, which could include a reduction in the translation of NAT9 mRNA into its protein product. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin could directly inhibit RNA polymerase II, resulting in a targeted decrease in the transcription of the NAT9 gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine may lead to the suppression of NAT9 expression by decreasing the methylation levels of its promoter, thereby reducing its transcription. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram may disrupt metalloenzyme function, potentially leading to a decrease in the enzymatic activity required for NAT9 gene transcription. | ||||||